SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-078080
Filing Date
2022-07-07
Accepted
2022-07-07 17:00:34
Documents
13
Period of Report
2022-07-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2220652d1_8k.htm   iXBRL 8-K 27945
2 EXHIBIT 3.1 tm2220652d1_ex3-1.htm EX-3.1 3430
  Complete submission text file 0001104659-22-078080.txt   207731

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20220707.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20220707_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20220707_pre.xml EX-101.PRE 22603
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2220652d1_8k_htm.xml XML 3721
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 221072209
SIC: 2834 Pharmaceutical Preparations